U07.1 COVID-19
Conditions
Interventions
Group 1: Asymptomatic, exercise capacity of patients will be assessed via spiroergometry, Bodyplethysmography and diffusion-capacity
Group 2: Symptomatic, no hospitalization
Group 3: Symptomatic and h
Sponsors
Franzen Institut
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Consent signed, clinically proven infection with SARS-CoV2
Exclusion criteria
Exclusion criteria: Persons who are under 18 years of age or over 80 years of age, who have an acute infection of the respiratory tract, who have another disease that prohibits heavy physical exertion, who have had a heart transplant, who have had heart surgery, who have had a heart attack, who have a congenital heart defect, who have had a lung transplant, who have reinfected themselves with iSARS-Cov2, who have poor German language skills, pregnant women, nursing mothers or who have not given written consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New changes in spiroergometry/body plethysmography 6 months after detected COVID infection | — |
Secondary
| Measure | Time frame |
|---|---|
| Persistent reduction of FVC and FEV1 Reduction of VO2max | — |
Countries
Germany
Contacts
Public ContactPatrick Huppertz
Universität zu Köln
Outcome results
None listed